Zealand Pharma unveils 2030 plan as weight loss competition heats up
Celsopupo | Stock | fake images Zealand Pharma outlined an ambitious five-year strategy for its anti-obesity portfolio on Thursday, highlighting…
Eli Lilly and company
Eli Lilly's weight-loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Eli Lilly to build $6 billion manufacturing plant in Alabama
Eli Lilly CEO David A. Ricks speaks at a news conference at Generation Park in Houston, Monday, Sept. 23, 2025.…
Eli Lilly cuts cash prices on vials of weight-loss drug Zepbound
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
Novo Nordisk shares fall after Alzheimer's drug trial falls short of target
A view shows a Novo Nordisk sign in front of its office in Bagsvaerd, outside Copenhagen, Denmark, July 14, 2025.…
Eli Lilly reaches $1 trillion market value, first for a healthcare company
A sign with the company's logo sits outside Eli Lilly's headquarters in Indianapolis, Indiana, on March 17, 2024. Scott Olson…
Novo Nordisk reduces Wegovy and Ozempic spot prices
Boxes of Ozempic and Wegovy manufactured by Novo Nordisk in a London pharmacy on March 8, 2024. Hollie Adams |…
Novo Nordisk pushes defense of its anti-obesity pill
A view shows a Novo Nordisk sign in front of its office in Bagsvaerd, outside Copenhagen, Denmark, July 14, 2025.…
Metsera considers that the new offer from Novo Nordisk is superior to that of Pfizer
The logos of Danish pharmaceutical company Novo Nordisk, maker of the successful diabetes and weight loss treatments Ozempic and Wegovy,…
Omada Health will begin prescribing GLP-1 and other obesity medications
The Omada Health logo is displayed on the screen of a smartphone. soup images | Light rocket | fake images…